Research Groups
Early Detection and Prevention - Prevention and Implementation Group
Previous Publications - All Publications 2012-2013
1. Morgan D.R., Torres J., Sexton R., Herrero R., Salazar-Martinez E., Greenberg E.R., Bravo L.E., Dominguez R.L., Ferreccio C., Lazcano-Ponce E.C., Meza-Montenegro M.M., Pena E.M., Pena R., Correa P., Martinez M.E., Chey W.D., Valdivieso M., Anderson G.L., Goodman G.E., Crowley J.J., Baker L.H. (2013) Risk of recurrent Helicobacter pylori infection 1 year after initial eradication therapy in 7 Latin American communities JAMA; 309(6):578-586. PMID: 23403682
2. Gonzalez P., Cortes B., Quint W., Kreimer A.R., Porras C., Rodriguez A.C., Jimenez S., Herrero R., Struijk L., Hildesheim A., Melchers W. (2012) Evaluation of the FTA carrier device for human papillomavirus testing in developing countries Journal of clinical microbiology; 50(12):3870-3876. PMID: 22993174
3. Castro F.A., Quint W., Gonzalez P., Katki H.A., Herrero R., Van Doorn L.J., Schiffman M., Struijk L., Rodriguez A.C., Del Vecchio C., Lowy D.R., Porras C., Jimenez S., Schiller J., Solomon D., Wacholder S., Hildesheim A., Kreimer A.R. (2012) Prevalence of and risk factors for anal human papillomavirus infection among young healthy women in Costa Rica Journal of infectious diseases; 206(7):1103-1110. PMID: 22850119
4. Li Q., Chuang S.C., Eluf-Neto J., Menezes A., Matos E., Koifman S., Wunsch-Filho V., Fernandez L., Daudt A.W., Curado M.P., Winn D.M., Franceschi S., Herrero R., Castellsague X., Morgenstern H., Zhang Z.F., Lazarus P., Muscat J., McClean M., Kelsey K.T., Hayes R.B., Purdue M.P., Schwartz S.M., Chen C., Benhamou S., Olshan A.F., Yu G., Schantz S., Ferro G., Brennan P., Boffetta P., Hashibe M. (2012) Vitamin or mineral supplement intake and the risk of head and neck cancer: pooled analysis in the INHANCE consortium International journal of cancer; 131(7):1686-1699. PMID: 22173631
5. Rodriguez A.C., Schiffman M., Herrero R., Hildesheim A., Bratti C., Sherman M.E., Solomon D., Guillen D., Alfaro M., Morales J., Hutchinson M., Cheung L., Wacholder S., Burk R.D. (2012) Low risk of type-specific carcinogenic HPV re-appearance with subsequent cervical intraepithelial neoplasia grade 2/3 International journal of cancer; 131(8):1874-1881. PMID: 22213126
6. Safaeian M., Ghosh A., Porras C., Lin S.W., Rodriguez A.C., Schiffman M., Wacholder S., Kemp T., Gonzalez P., Wentzensen N., Esser M., Meuree A., Matys K., Quint W., Van Doorn L.J., Sherman M.E., Herrero R., Pinto L.A., Hildesheim A. (2012) Direct Comparison of HPV16 Serological Assays Used to Define HPV-Naive Women in HPV Vaccine Trials Cancer epidemiology, biomarkers & prevention; 21(9):1547-1554. PMID: 22752082
7. Kreimer A.R., Schiffman M., Herrero R., Hildesheim A., Gonzalez P., Burk R.D., Porras C., Sherman M.E., Demuth F., Cheung L., Bratti C., Cecilia Rodriguez A. (2012) Long-term risk of recurrent cervical human papillomavirus infection and precancer and cancer following excisional treatment International journal of cancer; 131(1):211-218. PMID: 21823117
8. Kemp T.J., Safaeian M., Miner S., Williams M.C., Rodriguez A.C., Herrero R., Hildesheim A., Pinto L.A. (2012) Oral Immunoglobulin Levels are Not a Good Surrogate for Cervical Immunoglobulin Levels Frontiers in oncology; 61. PMID: 22737669
2. Gonzalez P., Cortes B., Quint W., Kreimer A.R., Porras C., Rodriguez A.C., Jimenez S., Herrero R., Struijk L., Hildesheim A., Melchers W. (2012) Evaluation of the FTA carrier device for human papillomavirus testing in developing countries Journal of clinical microbiology; 50(12):3870-3876. PMID: 22993174
3. Castro F.A., Quint W., Gonzalez P., Katki H.A., Herrero R., Van Doorn L.J., Schiffman M., Struijk L., Rodriguez A.C., Del Vecchio C., Lowy D.R., Porras C., Jimenez S., Schiller J., Solomon D., Wacholder S., Hildesheim A., Kreimer A.R. (2012) Prevalence of and risk factors for anal human papillomavirus infection among young healthy women in Costa Rica Journal of infectious diseases; 206(7):1103-1110. PMID: 22850119
4. Li Q., Chuang S.C., Eluf-Neto J., Menezes A., Matos E., Koifman S., Wunsch-Filho V., Fernandez L., Daudt A.W., Curado M.P., Winn D.M., Franceschi S., Herrero R., Castellsague X., Morgenstern H., Zhang Z.F., Lazarus P., Muscat J., McClean M., Kelsey K.T., Hayes R.B., Purdue M.P., Schwartz S.M., Chen C., Benhamou S., Olshan A.F., Yu G., Schantz S., Ferro G., Brennan P., Boffetta P., Hashibe M. (2012) Vitamin or mineral supplement intake and the risk of head and neck cancer: pooled analysis in the INHANCE consortium International journal of cancer; 131(7):1686-1699. PMID: 22173631
5. Rodriguez A.C., Schiffman M., Herrero R., Hildesheim A., Bratti C., Sherman M.E., Solomon D., Guillen D., Alfaro M., Morales J., Hutchinson M., Cheung L., Wacholder S., Burk R.D. (2012) Low risk of type-specific carcinogenic HPV re-appearance with subsequent cervical intraepithelial neoplasia grade 2/3 International journal of cancer; 131(8):1874-1881. PMID: 22213126
6. Safaeian M., Ghosh A., Porras C., Lin S.W., Rodriguez A.C., Schiffman M., Wacholder S., Kemp T., Gonzalez P., Wentzensen N., Esser M., Meuree A., Matys K., Quint W., Van Doorn L.J., Sherman M.E., Herrero R., Pinto L.A., Hildesheim A. (2012) Direct Comparison of HPV16 Serological Assays Used to Define HPV-Naive Women in HPV Vaccine Trials Cancer epidemiology, biomarkers & prevention; 21(9):1547-1554. PMID: 22752082
7. Kreimer A.R., Schiffman M., Herrero R., Hildesheim A., Gonzalez P., Burk R.D., Porras C., Sherman M.E., Demuth F., Cheung L., Bratti C., Cecilia Rodriguez A. (2012) Long-term risk of recurrent cervical human papillomavirus infection and precancer and cancer following excisional treatment International journal of cancer; 131(1):211-218. PMID: 21823117
8. Kemp T.J., Safaeian M., Miner S., Williams M.C., Rodriguez A.C., Herrero R., Hildesheim A., Pinto L.A. (2012) Oral Immunoglobulin Levels are Not a Good Surrogate for Cervical Immunoglobulin Levels Frontiers in oncology; 61. PMID: 22737669